Roche's CEO said on Wednesday that the Swiss drugmaker's oral drug candidate for breast cancer giredestrant could enter a ...

Roche's experimental oral drug for breast cancer giredestrant could enter a market worth at least 10 billion Swiss francs ...

In Boston, we remember his Red Sox career from 1971-78. Specifically, the 1975 season when Tiant had 18 wins and 18 complete ...

Erik ten Hag's role as Manchester United manager will be scrutinised today at a planned meeting of the club's leadership in ...

David Roche, strategist at Quantum Strategy, says the Federal Reserve's initial jumbo cut gives markets the wrong impression ...

Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

A decade into reformulating Pfizer’s oral renal cell carcinoma drug Inlyta (axitinib) into a treatment that can be injected ...

A new survey commissioned by Big Pharma Roche has found that half of those polled “have either limited or no awareness” of ...

The agreement's goal is to bring a blood-based test to market to stratify patients with traumatic brain injuries.

Basecamp Research, a biotechnology company that uses artificial intelligence to discover novel proteins and to help create ...

Here's everything you need to know about keeping your family safe all year round with the dermatologist-tested, SPF50+ La ...

Addressing employment, Roche noted that while the job market has softened, it has not resulted in significant layoffs.